FDA gets OK from China to station inspectors there; Brazil lays out CMO rules; B. Braun responds to U.K. alert;

> Pacira Pharmaceuticals has submitted a Prior Approval Supplement (PAS) with the FDA for an additional bulk manufacturing suite for Exparel (bupivacaine liposome injectable suspension), manufactured at the Science Center Campus in San Diego, CA. Release

> China's drug watchdog has banned imports of a set of antibiotic injection products manufactured by a Republic of Korea (ROK) pharmaceutical company due to its refusal to accept spot checks. Story

> China will finally allow the FDA to station 10 inspectors in the country. Report

> Brazil is asking contract manufacturers and companies providing quality control services and warehousing to comment on its proposed regulations. Item

> The Philippines' FDA has recalled the antibacterial drug Clarie DS 250 because it did not meet specifications. Report

> B. Braun Melsungen has changed stopper suppliers for its sodium bicarbonates after detecting aluminum salt precipitation in retained samples, leading the U.K. to issue an alert. Story

> The European Bank for Reconstruction & Development intends to sell a stake in the Russian vaccine producer NPO Petrovax that it acquired in 2008 when it invested in an NPO manufacturing facility. Report

And Finally... A San Diego, CA, pharmacy and its owner have pleaded guilty to charges of ordering more than $750,000 worth of unapproved foreign cancer drugs and charging their cost to Medicare. Notice